Gene: PNPLA4
Official Full Name: patatin like domain 4, phospholipase and triacylglycerol lipaseprovided by HGNC
Gene Summary: This gene encodes a member of the patatin-like family of phospholipases. The encoded enzyme has both triacylglycerol lipase and transacylase activities and may be involved in adipocyte triglyceride homeostasis. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome Y. [provided by RefSeq, Feb 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34285 | PNPLA4 Knockout cell line (HeLa) | Human | PNPLA4 | 1:3~1:6 | Negative | Online Inquiry |
KO34286 | PNPLA4 Knockout cell line (HCT 116) | Human | PNPLA4 | 1:2~1:4 | Negative | Online Inquiry |
KO34287 | PNPLA4 Knockout cell line (HEK293) | Human | PNPLA4 | 1:3~1:6 | Negative | Online Inquiry |
KO34288 | PNPLA4 Knockout cell line (A549) | Human | PNPLA4 | 1:3~1:4 | Negative | Online Inquiry |
PNPLA4 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of the PNPLA4 gene, which encodes for a protein involved in lipid metabolism and energy homeostasis. These engineered cell lines exhibit a complete disruption of the PNPLA4 gene, enabling researchers to investigate the gene's role in various biological processes, including lipid droplet dynamics and cellular signaling pathways.
The primary function of the PNPLA4 knockout cell lines is to serve as a powerful tool for elucidating the molecular mechanisms regulated by PNPLA4 and its impact on lipid storage and mobilization. The knockout approach, utilizing CRISPR/Cas9 gene-editing technology, ensures a precise alteration in the genomic sequence, resulting in a significant reduction or absence of PNPLA4 protein expression. This model allows for the exploration of how the absence of PNPLA4 influences metabolic pathways, potentially leading to greater insights into diseases associated with lipid dysregulation, such as obesity or non-alcoholic fatty liver disease.
Scientifically, the applications of PNPLA4 knockout cell lines are vast. They enable researchers in both academic and clinical settings to dissect molecular mechanisms underlying metabolic disorders and provide a platform for the screening of novel therapeutics. Additionally, these cell lines can facilitate the exploration of interactions between PNPLA4 and other metabolic pathways, proving essential in the ongoing quest to understand complex diseases at the cellular level.
Compared to traditional wild-type cell lines, PNPLA4 knockout cell lines offer distinct advantages, including enhanced specificity in drug response assays and the ability to perform targeted studies on lipid metabolism without confounding variables associated with unaltered PNPLA4 expression. This specificity provides more reliable data and accelerates the pace of research.
Ultimately, the value of PNPLA4 Gene Knockout Cell Lines to researchers, clinicians, and the broader scientific community lies in their ability to illuminate the critical functions of PNPLA4 and its implications in human health. They represent a step forward in precision research, leading to new insights and potential clinical applications.
With years of expertise in developing innovative biological products, our company is committed to advancing scientific knowledge by providing high-quality research tools that empower researchers to unlock the complexities of cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.